Connective Tissue Disorders and What Testing Shows

Medically reviewed by Brandon Colby, MD, last reviewed Oct 16, 2026

Short answer: Connective tissue disorders are a broad group of conditions that affect the skin, blood vessels, bones and other structures. Genetic testing can find the mutation behind some of them, such as Hajdu-Cheney syndrome, osteogenesis imperfecta and pseudoxanthoma elasticum, but not every connective tissue disorder has a known genetic cause.

Connective tissue is the biological glue that holds our body together, providing support, strength, and elasticity to various organs and tissues. Abnormalities in connective tissue can lead to a wide range of disorders, affecting the skin, blood vessels, bones, and other vital structures. In this article, we will delve into the complex world of connective tissue disorders, exploring how genetic testing can help in understanding, diagnosing, and managing these conditions.

Unraveling the Genetic Basis of Connective Tissue Disorders

Recent advances in genetics have shed light on the underlying causes of many connective tissue disorders. These conditions can be broadly classified into syndromic and non-syndromic disorders, depending on whether they are associated with a specific set of symptoms or not. Some examples of syndromic disorders include Hajdu-Cheney Syndrome, Osteogenesis Imperfecta, and Pseudoxanthoma Elasticum, while non-syndromic disorders encompass a wide range of congenital, neuromuscular, and idiopathic scoliosis conditions [1].

Using Genetic Testing to Diagnose Connective Tissue Disorders

Genetic testing can be a valuable tool in diagnosing connective tissue disorders, as it identifies the specific genetic mutations responsible for the condition. For instance, a case report of a 14-year-old male with Hajdu-Cheney Syndrome, a rare autosomal dominant congenital disorder, revealed that genetic testing was crucial in confirming the diagnosis [2]. Similarly, genetic testing can help identify mutations responsible for Osteogenesis Imperfecta, a disorder causing increased susceptibility to fractures [3], and Pseudoxanthoma Elasticum, which affects the skin, eyes, and blood vessels [4].

Guiding Treatment Strategies with Genetic Testing

Genetic testing can also play a crucial role in guiding treatment strategies for connective tissue disorders. For example, in the case of Osteogenesis Imperfecta, knowing the specific genetic mutation can help determine the severity of the condition and inform the appropriate treatment approach [3]. In some cases, genetic testing can also help identify potential complications associated with the disorder, allowing for better management and prevention of these issues.

Benefits and Limitations of Genetic Testing for Connective Tissue Disorders

Genetic testing offers several benefits in the context of connective tissue disorders, including:

Improved diagnostic accuracy
Personalized treatment strategies
Identification of at-risk family members
Guidance for reproductive decision-making

However, it is important to recognize the limitations of genetic testing. Not all connective tissue disorders have a known genetic cause, and in some cases, the identified mutation may not be clearly linked to the observed symptoms. Additionally, genetic testing can be expensive and may not be covered by insurance, posing a barrier to access for some individuals.

Embracing the Future of Connective Tissue Disorder Management

As our understanding of the genetic basis of connective tissue disorders continues to grow, genetic testing will undoubtedly play an increasingly important role in diagnosis and treatment. By identifying the specific genetic mutations responsible for these conditions, we can better understand their underlying mechanisms, develop targeted therapies, and ultimately improve the lives of those affected by these disorders.

It is essential for healthcare providers and patients to stay informed about the latest advances in genetic testing and to carefully weigh the benefits and limitations of these tests when considering their use in managing connective tissue disorders.

Get Tested With Whole Genome Sequencing

Whole genome sequencing reads 100% of your DNA, which includes genes linked to many connective tissue conditions. Sequencing's Kit Bundles include a Whole Genome Sequencing kit and Next Gen Disease Screening, which analyzes your genome for more than 15,000 conditions. Bring your results to a doctor who knows connective tissue disorders.

Shop All Whole Genome Sequencing Kit Bundles

Frequently Asked Questions About Connective Tissue Disorders

What are connective tissue disorders?

Connective tissue supports organs and tissues and gives them strength and elasticity. Abnormalities in connective tissue can lead to a wide range of disorders that affect the skin, blood vessels, bones and other structures.

Can genetic testing diagnose connective tissue disorders?

For many of them, yes. Testing can identify the specific genetic change responsible for a condition such as Hajdu-Cheney syndrome, osteogenesis imperfecta or pseudoxanthoma elasticum. Not all connective tissue disorders have a known genetic cause.

What is the difference between syndromic and non syndromic disorders?

Syndromic disorders come with a specific set of symptoms. Examples include Hajdu-Cheney syndrome, osteogenesis imperfecta and pseudoxanthoma elasticum. Non syndromic disorders include a wide range of congenital, neuromuscular and idiopathic scoliosis conditions.

What are the benefits of genetic testing for connective tissue disorders?

Benefits include more accurate diagnosis, treatment plans tailored to the person, identifying family members who may be at risk, and guidance for decisions about having children.

What are the limits of genetic testing for connective tissue disorders?

Not every disorder has a known genetic cause, and a change that is found may not be clearly linked to a person's symptoms. Testing can also be expensive and may not be covered by insurance.

Does Sequencing test for connective tissue disorders?

Sequencing's whole genome sequencing reads 100% of your DNA, so your results can be reviewed for genes linked to many connective tissue conditions. Bring your results to a doctor who knows connective tissue disorders.

References

Giampietro P. Progress in understanding genetic contributions in syndromic and non syndromic disorders associated with congenital scoliosis. In: The Genetics and Development of Scoliosis. 2009:127-152. doi:10.1007/978-1-4419-1406-4_7
Hearing assessment in a rare case of Hajdu Cheney syndrome. Int J Otorhinolaryngol Head Neck Surg. 2017;3:1140. doi:10.18203/issn.2454-5929.ijohns20174352
Keegan M, Whatcott B, Harrison B. Osteogenesis imperfecta, perioperative bleeding, and desmopressin. Anesthesiology. 2002;97:1011-1013. doi:10.1097/00000542-200210000-00039
Marchione R, Kim N, Kirsner R. Pseudoxanthoma elasticum: new insights. J Invest Dermatol. 2009;129:258. doi:10.1038/jid.2008.407

This article is for education and is not a substitute for professional medical advice, diagnosis, or treatment. Talk to a qualified healthcare provider about your own health.